Resumen

CORTES-ACEVEDO, Paulina; MENDOZA-ELVIRA, Susana E.; DOFFINGER, Rainer  y  BARCENAS-MORALES, Gabriela. Secondary immunodeficiencies related to the presence of anti-cytokine autoantibodies. Gac. Méd. Méx [online]. 2023, vol.159, n.2, pp.157-163.  Epub 24-Abr-2023. ISSN 2696-1288.  https://doi.org/10.24875/gmm.22000338.

Anti-cytokine autoantibodies (ACAA) have been reported to be an important cause of secondary immunodeficiencies. High titers of neutralizing autoantibodies may cause susceptibility to different life-threatening infectious diseases. For example, neutralizing autoantibodies against IFNγ have been reported to be correlated with susceptibility to mycobacterial infections and intracellular fungal pathogens. Autoantibodies against IL-6 were detected in patients with subcutaneous abscesses and recurrent staphylococcal cellulitis; on the other hand, patients with cryptococcosis, nocardiosis, and pulmonary alveolar proteinosis were positive for autoantibodies to GM-CSF. A relationship has also been established between autoantibodies against IL-17 and IL-22 and chronic mucosal Candida infections, which have been identified in patients with APECED or thymoma. Autoantibodies against type-I IFN have been recently reported during the onset of acute COVID-19. These ACAAs resemble genetic defects in cytokines or their signaling pathways. Therefore, they may be considered to be primary immunodeficiencies phenocopies. Consequently, the detection of ACAA could be important in the diagnosis of patients, particularly in the case of late-onset diseases, in order to decide appropriate treatments. This review presents an overview of current understanding of ACAA-associated secondary immunodeficiencies.

Palabras llave : Anti-cytokine antibodies; Anti-GM-CSF; Anti-IFNγ; Anti-IL-6; Secondary immunodeficiency.